sulfaperin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
anti-infectives, sulfonamides 2522 599-88-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sulfaperin
  • 5-Methylsulfadiazine
  • demosulfan
  • isosulfamerazine
  • sulfaperine
  • sulfatreis
  • Molecular weight: 264.30
  • Formula: C11H12N4O2S
  • CLOGP: 0.60
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 2
  • TPSA: 97.97
  • ALOGS: -2.93
  • ROTB: 2

Drug dosage:

DoseUnitRoute
0.50 g O

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -0.684 Moderate 0.68
caco2-efflux Caco-2 efflux ratio (BA/AB) 1.932 Moderate 0.68
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 11.429 10^-6 cm/s Moderate 0.68
dh-clint Dog hepatocyte intrinsic clearance 1.858 uL/min/10^6 cells Moderate 0.68
dppb Dog plasma protein binding (% unbound) 48.270 % Moderate 0.68
fcs-ppb Fetal calf serum protein binding (% unbound) 56.020 % Moderate 0.68
herg hERG pIC50 3.901 pIC50 Moderate 0.68
hh-clint Human hepatocyte intrinsic clearance 1.629 uL/min/10^6 cells Moderate 0.68
hlm-clint Human liver microsomal intrinsic clearance 3.170 uL/min/mg protein Moderate 0.68
hppb Human plasma protein binding (% unbound) 29.280 % Moderate 0.68
kinase-safety-class ACVR2A,ACVR2B,ALK,AURKA,AURKB,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,CHEK1,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,ITK,JAK1,JAK2,MAP3K1,MAP3K21,MAP3K7,MAP4K1,MAPK7,MAPK9,MARK4,MTOR,NTRK2,PDK2,PDK4,PIK3CB,PIM2,PRKCD,PRKDC,SGK1,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1 46
kinase-selectivity-class AURKA,DDR1,GRK2,SIK2 4
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 3.148 Moderate 0.68
mh-clint Mouse hepatocyte intrinsic clearance 2.793 Moderate 0.68
mppb Mouse plasma protein binding (% unbound) 52.420 Moderate 0.68
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 1.977 Moderate 0.68
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 55.330 % Moderate 0.68
rh-clint Rat hepatocyte intrinsic clearance 0.764 uL/min/10^6 cells Moderate 0.68
rh-fuinc Rat hepatocyte fraction unbound in incubation 95.170 % Moderate 0.68
rppb Rat plasma protein binding (% unbound) 16.790 % Moderate 0.68
solubility-dd Solubility at pH 7.4 in DMSO 926.830 uM Moderate 0.68

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC J01ED06 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
SULFONAMIDES AND TRIMETHOPRIM
Long-acting sulfonamides
CHEBI has role CHEBI:33282 antibacterial agent
CHEBI has role CHEBI:36047 antibacterial drug

Related Drugs by ATC class:

J01ED Long-acting sulfonamides 8 drugs
sulfadimethoxinesulfalenesulfamazonesulfamerazinesulfametersulfamethoxypyridazinesulfametomidinesulfaphenazole

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 6.59 acidic
pKa2 2.27 Basic
pKa3 1.65 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D07240 KEGG_DRUG
C0075523 UMLSCUI
CHEBI:131722 CHEBI
CHEMBL2105499 ChEMBL_ID
DB13320 DRUGBANK_ID
68933 PUBCHEM_CID
12742 IUPHAR_LIGAND_ID
C012049 MESH_SUPPLEMENTAL_RECORD_UI
1399 INN_ID
W5E840UV9P UNII

Pharmaceutical products:

None